Get started
Author

Emma Irene Andersson

Observed names: Andersson, Emma, E Andersson, E I Andersson, E. Andersson, E. I. Andersson, Emma Andersson, Emma I Andersson, Emma I. Andersson
ORCID: 0000-0002-3986-9892
Observed ORCID: 0000-0002-3986-9892
OpenAlex ID: A5086588914
Somatic STAT3 Mutations in Large Granular Lymphocytic Leukemia
2012 · Hanna L.M. Koskela, Samuli Eldfors, et al. · New England Journal of Medicine · 777
PDF
Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia
2013 · Hanna L. M. Rajala, Samuli Eldfors, et al. · Blood · 294
Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target
2018 · Olli Dufva, Matti Kankainen, et al. · Nature Communications · 139
PDF
Somatic mutations in clonally expanded cytotoxic T lymphocytes in patients with newly diagnosed rheumatoid arthritis
2017 · P. Savola, T. Kelkka, et al. · Nature Communications · 117
PDF
Drug-perturbation-based stratification of blood cancer
2017 · Dietrich, Sascha, Oleś, Małgorzata, et al. · Kölner Universitäts PublikationsServer (Universität zu Köln) · 109
PDF
Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL
2018 · A. Schrader, G. Crispatzu, et al. · Nature Communications · 106
PDF
High incidence of activating STAT5B mutations in CD4-positive T-cell large granular lymphocyte leukemia
2016 · Emma I. Andersson, Takahiro Tanahashi, et al. · Blood · 104
PDF
Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia
2014 · M Kontro, H Kuusanmäki, et al. · Leukemia · 103
The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia
2014 · H. L. M. Rajala, T. Olson, et al. · Haematologica · 99
PDF
Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling
2017 · E I Andersson, S Pützer, et al. · Leukemia · 95
ADA2 deficiency: Clonal lymphoproliferation in a subset of patients
2018 · Luca Trotta, Timi Martelius, et al. · Journal of Allergy and Clinical Immunology · 90
PDF
Detection of KRAS mutations in liquid biopsies from metastatic colorectal cancer patients using droplet digital PCR, Idylla, and next generation sequencing
2020 · Matilda Holm, Emma Andersson, et al. · PLoS ONE · 77
PDF
Patient-Customized Drug Combination Prediction and Testing for T-cell Prolymphocytic Leukemia Patients
2018 · Liye He, Jing Tang, et al. · Cancer Research · 75
Activating somatic mutations outside the SH2-domain of STAT3 in LGL leukemia
2015 · E Andersson, H Kuusanmäki, et al. · Leukemia · 74
Novel somatic mutations in large granular lymphocytic leukemia affecting the STAT-pathway and T-cell activation
2013 · E I Andersson, H L M Rajala, et al. · Blood Cancer Journal · 64
PDF
Genomic landscape characterization of large granular lymphocyte leukemia with a systems genetics approach
2017 · A Coppe, E I Andersson, et al. · Leukemia · 36
PDF
CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemia
2020 · Carlos Cuesta-Mateos, Patricia Fuentes, et al. · Biomarker Research · 29
PDF
STAT3 Mutation Is Associated with STAT3 Activation in CD30+ ALK− ALCL
2020 · Emma I. Andersson, Oscar Brück, et al. · Cancers · 26
PDF
Multi-parametric single cell evaluation defines distinct drug responses in healthy hematologic cells that are retained in corresponding malignant cell types
2019 · Muntasir M. Majumder, Aino-Maija Leppä, et al. · Haematologica · 26
PDF
Novel drug candidates for blast phase chronic myeloid leukemia from high-throughput drug sensitivity and resistance testing
2015 · P O Pietarinen, T Pemovska, et al. · Blood Cancer Journal · 25
PDF
Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitors
2017 · Paavo O. Pietarinen, Christopher A. Eide, et al. · Oncotarget · 16
PDF
Novel TBL1XR1, EPHA7 and SLFN12 mutations in a Sezary syndrome patient discovered by whole exome sequencing
2014 · Emma Andersson, Samuli Eldfors, et al. · Experimental Dermatology · 13
PDF
Circulating tumor DNA is a prognostic biomarker in metastatic melanoma patients treated with chemoimmunotherapy and BRAF inhibitor
2022 · Kalle E. Mattila, Siru Mäkelä, et al. · Acta Oncologica · 4
A guilt-by-association mutation network in LGL leukemia
2017 · Emma I. Andersson, Alessandro Coppe, et al. · Oncotarget · 3
PDF
Discovery of STAT5b Mutations and Small Subclones of STAT3 Mutations in Large Granular Lymphocytic (LGL) Leukemia
2012 · Hanna L M Rajala, Samuli Eldfors, et al. · Blood · 3
Works count: 52
Citation count: 2,513
H-index: 20
I10-index: 22
Year
Topic
Type